Form 4 · Filed May 2, 2026, 01:35 AM UTC
SYRE/Spyre Therapeutics, Inc.
Burrows Scott L — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 1, 2026 | M | other | 12,500 | $15 | $181,250 | 110,494 |
| May 1, 2026 | S | sell | 12,500 | $71 | $892,125 | 97,994 |
| May 1, 2026 | M | other | 12,500 | $0 | — | 382,357 |
Source: SEC EDGAR raw filing ↗ · Accession 0001853327-26-000005